Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

2 Nov 2016 07:00

RNS Number : 0468O
Biome Technologies PLC
02 November 2016
 

[02 November 2016]

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Trading Update

 

Biome Technologies plc today publishes its trading update for the nine month period ended 30 September 2016.

 

Total Group revenues achieved in Q3 were £0.9m (2015: £1.3m). This takes Group revenues for the nine months to 30 September 2016 to £3.1m, 7% behind the prior year period (2015: £3.3m).

 

Net increase in cash and cash equivalents in the period was £0.2m taking the Group's cash position at 30 September 2016 to £1.2m (30 June 2016 £1.0m).

 

Bioplastics Division

 

Revenues in the Bioplastics division in Q3 were £0.3m (Q3 2015 £0.5m), resulting in revenues in the first nine months of the financial year being £0.9m (2015: £1.5m).

 

The Bioplastics division is developing a closely related suite of materials to enable coffee pod producers to sell biodegradable end products principally to the US consumer market. These comprise first, the outer packaging and the lid (now fully commercial); next, the ring of the pod; and lastly, the "non-woven" filter of the pod. The latter two materials are in the late stages of development.

 

The subdued turnover resulted principally from the timing of end market campaign runs of the commercialised packaging and lidding materials. Encouragingly, some £0.6m of orders have already been received for Q4.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q3 were £0.7m (Q3 2015: £0.8m), resulting in revenues in the first nine months of the financial year being £2.2m (2015: £1.9m).

 

The RF Technologies division sells a range of products using radio frequency technology, principally in the fibre optic market, and has been developing ways in which to expand this product portfolio into other market segments.

 

The order outlook in the fibre optic furnace market is strong and there are good signs of increased appetite for capacity investment in this sector.

 

 

 

Outlook

Group revenues for the second half of 2016 and the early part of 2017 will continue to reflect the volatility related to the new products of the Bioplastic division as they move from their development to commercialisation phases.

 

The Board expects Group revenues for the year to 31 December 2016 to be around the same level as those achieved in 2015.

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKDDNOBDDNDK
Date   Source Headline
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.